Human pial arteries and intraparenchymal microvessels were isolated for enzyme assays and radio ligand binding studies of receptors, Special attention was paid to contamination with brain tissue, which was as sessed by luxol staining and cerebroside assays for myelin and by scanning electron microscopy, The amount of contamination was �1% for pial vessels and 14% for microvessel preparations, Significant levels of <xj-adre noreceptors (binding sites for [3H]prazosin) and <x2-adre-Abbreviations used: EDTA, ethylenediaminetetraacetate; QNB, quinuc1idinyl benzilate.
In the last 20 years there has been increasing in terest in the possibility that adrenergic and cholin ergic substances play a role in the modulation of cerebral blood flow, pressure, and the permeability of the blood-brain barrier. The presence of adren ergic and cholinergic nerves in the cerebral arteries of laboratory animals has been indicated by fluo rescence microscopy (Edvinsson et a!. , 1976; Bar amidze et a!. , 1982) , acetylcholinesterase staining (Borodulya and Pletchkova, 1976; Denn and Stone, 1976; Edvinsson et a!. , 1976) , and electron micros copy (Iwayama et aI. , 1970; Nielsen et a!. , 197 1) . In addition, responses to the application of agonists and antagonists to superficial cerebral arteries in vivo (Kuschinsky et a!. , 1974) and to isolated strips or rings of pial arteries in vitro (Duckles and Bevan, 1976; Edvinsson et aI. , 1976 Edvinsson et aI. , , 1977 Lee et a!. , 1978; Duckles, 1979) have shown the presence of u-and muscarine receptors. lntraparenchymal vessels have been more difficult to study because of their location and small size. The responsiveness of these smaller vessels has been inferred from studies of cerebral blood flow (Matsuda et aI. , 1976; ; however, these studies are compli cated by the fact that catecholamines and acetyl choline modify cerebral metabolism, with sec ondary effects on blood flow. Biochemical mea surements of radioligand binding to receptors have suggested the presence of some U-, [3-, and mus carine receptors in pial vessels (Friedman and Davis, 1980; Krause et a!. , 1980; Estrada and Krause, 1982; Tsukuhara et a!. , 1983) and intrapa renchymal microvessels (Peroutka et al. , 1980; Harik et a!. , 198 1; Kobayashi et aI., 198 1; Estrada et aI. , 1983) from various animal species. However, uJ adrenoreceptors have not been clearly demon strated in pial vessels, and the presence of mus carine receptors in microvessels has been contro versial.
Studies of human cerebral vessels are scarce and important because of the difficulty of carrying out physiological investigations with human tissues and considerable species variations in animals (Duckles et a!., 1977; Duckles, 1979; Lee et a!. , 1982) . The purpose of the present study was to determine the presence of muscarine, U l -' and u2-receptors in human pial arteries and intraparenchymal micro vessels. Special emphasis was given to identifying the degree of contamination of vascular tissue with fragments of brain parenchyma.
METHODS

Human brain tissue
Frontotemporal lobes of brains from eight 20-to 50year-old male accident victims were obtained 4-10 h postmortem. Tissue was kept at 4°C for up to I h until vessels could be isolated. Many studies attest to the sta bility of receptors and enzymes in postmortem tissue (e.g., Spokes and Koch, 1978; Puymirat et aI., 1979) .
Isolation of pial vessels
Frontopolar, orbital, and callosomarginal branches of the anterior cerebral artery were isolated essentially as described by Krause et al. (1980) . In brief, pia-arachnoid membranes were stripped from underlying brain tissue, and pial arteries were dissected at 4°C with the help of a dissecting microscope. This procedure yields clean pial vessels, but occasional tiny pieces of brain tissue remain associated with arterioles that penetrate from pial vessels into brain parenchyma. Vessels were collected in ice-cold 0.25 M sucrose buffered with 5 mM Tr is-HCI at pH 7.4 (buffered sucrose), and homogenized in a Polytron PIO blender at top speed for 30 s. Large fragments were re moved by centrifugation at 900 g for 10 min, and pieces of pial vessels were sedimented from the supernatant fluid at 26,800 g for 10 min. The pellet was frozen until used for assays.
Isolation of microvessels
After the removal of pia-arachnoid membranes, cere bral tissue was homogenized in 4 volumes of ice-cold buffered sucrose in a Waring blender at top speed for 10 s. This suspension was further homogenized in a glass tube with a motor-driven Te flon pestle, and poured over a 211-fLm nylon mesh filter. Retained material was rinsed, resuspended by hand in an all-glass homogenizer, and sieved again. Vessels on the filter were resuspended in buffered sucrose plus 25% bovine serum albumin, and centrifuged for 45 min at 1,075 g. The soft pellet was resuspended in fresh sucrose buffer with albumin, and the centrifugation was repeated. The second pellet was resuspended in fresh sucrose buffer and microvessels were sedimented at 27,000 g for 10 min. The resulting pellet was frozen until used.
Receptors in brain tissue
Samples of frontal cortex were homogenized with a Polytron PIO blender in either 50 mM sodium phosphate buffer with 10 mM ethylenediaminetetraacetate (EDTA) at pH 7.4 or 50 mM Tr is-HCI buffer with I mM EDTA at pH 7.4, using 20 ml/g tissue. Membranes were then cen trifuged at 27,000 g for 10 min and frozen until used.
Binding assays
Pellets of homogenized vessels were thawed and re suspended in 50 mM phosphate buffer, pH 7.4, containing 10 mM EDTA for assays of muscarine receptors, and in 50 mM Tr is-HCI, pH 7.7, plus I mM EDTA for assays of a-adrenoreceptors. In each case 20 ml of buffer was used per gram of pellet.
Assay of muscarine receptors
Assays were as described previously (Potter et al., 1984) . In brief, membranes from 5-10 mg of isolated ves sels or frontal cortex were incubated in triplicate in 10 ml of 50 mM sodium phosphatell mM EDTA, pH 7.4, with 1 nM (-)[3HJquinuclidinyl benzilate ([3HJQNB) (33 Ci/ mmol; New England Nuclear Corp.) for 30 min at 37°C. An additional set of tubes for nonspecific binding con tained I fLM (±)QNB. Membranes were collected on glass fiber filters, rinsed, dried, and counted for radio activity by liquid scintillation spectroscopy. The Kd for QNB for muscarine receptors is 5-8 pM in human as well as rat and rabbit brain tissue (Potter et aI., 1984) , so I nM ( -)[3H1QNB saturates >99% of all known muscarine receptors. Nonspecific binding for vessel preparation varied from 35 to 50% of total binding.
Assay of lYcreceptors
Membranes from 5 mg of tissue were incubated in trip licate with 3 nM [3Hlprazosin (17.1 Cilmmol; New En gland Nuclear Corp.) ± 3 fLM prazosin (Pfizer) for blanks (prepared in 0.1 % I-ascorbic acid) in 1 ml of 50 mM Tr is HCI buffer at pH 7.7 for 30 min at 2YC. Membranes were filtered, washed, dried, and counted as for muscarine re ceptors. The Kd for prazosin has been reported to be 0.14-0.31 nM for brain and 0.1-0.9 nM for peripheral tissues (Bylund and U'Prichard, 1983) , so 3 nM [3Hlprazosin should label at least 75% of all known aj receptors. Nonspecific binding for vessel preparations was 30-50% of total binding.
Assay of lYrreceptors
Membranes from 5 mg of tissue were incubated in trip licate with 3 nM [3Hlazidoclonidine (9 Cilmmol; New En gland Nuclear Corp.) ± 3 fLM aminoclonidine (Sigma Corp.) for nonspecific binding in 1 ml of 50 mM Tr is-HCl buffer with 1 mM MgCI, at pH 7.7 for 45 min at 2Ye. Incubations were performed in the dark, and after filtra tion but before washing, membranes on filters were ex posed to ultraviolet light for 5 min to photoactivate the radio ligand for irreversible binding (Ernsberger and U'Prichard, 1983) . Filters were then washed, dried, and counted as for muscarine receptors. The Kd for this ligand is 1-3 nM (Bylund and U'Prichard, 1983) , so 3 nM should yield at least 50% saturation. Nonspecific binding was 40-60% of total binding.
Assay for choline acetyltransferase activity
The choline acetyltransferase assay was performed as described by Fonnum (1968) .
Cerebroside determination
The amount of cerebrosides (a main component of myelin) was measured as an indication of contamination with pieces of brain tissue. The method (Hess and Lewin, 1965) involves the determination of galactose, the main sugar in cerebrosides, with an orcinol/H2S04 reagent. Lipids were extracted from membrane suspensions of frontal cortex, pial vessels, and microvessels; and gan gliosides were separated from cerebrosides with aqueous/ organic solvents. The assay product was determined in a spectrophotometer at 425 nm.
Scanning electron microscopy
Fresh pial and intraparenchymal vessels were sedi mented in buffered sucrose. The pellets were fixed in 3% glutaraldehyde/cacodylate buffer and then in 1% OS04 for 60 min each. After being dried by the critical point method from CO" the pellets were mounted on stubs, coated with gold,-and examined in a scanning electron microscope.
RESULTS
Purity of vessel preparations
In both pial vessel and microvessel preparations, the presence of contaminating brain material was assessed in three ways. First, luxol-stained vessels were examined by light microscopy for myelin. Since nerves are believed to lose their myelin sheath when approaching the tunica adventitia of arteries (Nielsen et aI. , 197 1), myelin in vessel prep arations can be attributed primarily to adherent pieces of brain tissue. Most pial arteries showed no observable blue-green staining characteristic of myelin, but tiny pieces of stained tissue were found trapped in tangled microvessels, even after repeated homogenization, sieving, and centrifugation steps. Second, vessels were studied by scanning electron microscopy. Representative micrographs for pial and intraparenchymal vessels are shown in Figs. I and 2, respectively. Pial vessels varied in size from 10 to 500 /-Lm in external diameter. Nerve plexuses were readily identifiable ( Fig. I A) , as were small pieces of pia-arachnoid membranes still attached to vessel walls (Fig. IB) . There was no identifiable contamination with brain tissue. Smaller microves sels, however, showed some adherent small pieces of tissue, presumably brain parenchyma (Fig. 2) .
Third, the cerebroside content of vessel prepara tions was measured (Table O . The amount of ce rebroside in pial vessels was I % of that in frontal cortex, a very low level of contamination in agree ment with microscopic observations. In contrast, microvessels contained 14% as much cerebroside as the cortex, again in accord with visual findings. These results suggest that biochemical measure ments of receptors and enzyme levels in pial vessels are likely to be more biologically significant than in microvessels. To be conservative, we have consid ered that percentages of receptors and enzyme levels in both vessel preparations below the deter mined percentages of contamination may be arti factual.
Results of assays
Ta ble 1 shows the results of all assays performed with pial and intraparenchymal vessels. It is clear that these vessel preparations showed significantly lower levels of radioligand binding, choline acetyl transferase activity, and cerebroside content than frontal cortex. Figure 3 shows a graphic comparison between these results when values are expressed as a percentage of the levels for cerebral frontal cortex. In both pial arteries and microvessels, the levels of binding of [3H]prazosin and [3H]azi- doclonidine appeared in excess of what might be expected on the basis of contamination by brain tissue, indicating the presence of <XI-and <X2-adre noreceptors in both preparations. In comparison, levels of binding of [3H]QNB and choline acetyl transferase activity appeared to exceed those ex pected on the basis of contamination in pial arteries, but not microvessels. The absolute levels of binding for each of these radioligands are within a factor of 6, but should not be compared rigorously because 46.0 ± 9.2 0.5 ± 0.1 6.4 ± 0.8
Values are means ± SEM from 5-10 separate assays, each carried out in triplicate.
of uncertainties as to the levels of receptor satura tion achieved. In general, it is our experience and that of others using radioligand binding assays (with antagonists) for receptors that K d values do not differ significantly from one mammalian species or tissue to another. If K d values in human vessels are like those found for the present radioligands in other mammalian tissues (see Methods), then it is pos sible to conclude further from the data in Ta ble 1 that human pial arteries have somewhat more <XI receptors than muscarine or <X2-receptors.
DISCUSSION
Anatomical studies have offered a clear picture of the distribution of adrenergic and cholinergic nerves in cerebral vessels. With catecholamine flu orescence and acetylcholinesterase-staining tech niques, the density and distribution of adrenergic and cholinergic fibers have been shown to be very similar in pial arteries of several animals and of hu mans (Edvinsson et aI. , 1976; Baramidze et aI. , 1982) . By electron microscopy, nerve terminals with dense-core and empty vesicles have been pressed as a percentage of the levels for frontal cortex. The standard errors of the percentages were calculated by stan dard formulas (Chase and Rabinowitz, 1967) . The horizontal dashed line represents the estimated levels of contamination of vessels with brain tissue. The unpooled t test was used to compare means since variances could not be assumed to be equal. CAT, choline acetyltransferase; QNB, quinuclidinyl benzilate; AZC, azidoclonidine. Differences between the ce rebroside content and each of the other four determinations: *p < 0.05; "p < 0. 10; ***p < 0.20.
found in close apposition in the outer layers of pial arteries (lwayama et ai., 1970; Nielsen et ai., 1971) . Only adrenergic fibers disappear after superior cer vical ganglionectomy (Edvinsson, 1975) . Sympa thetic innervation is also apparent in intracerebral vessels; however, neither cholinesterase staining nor electron microscopy has suggested cholinergic innervation in these vessels (Edvinsson, 1975) . Thus, there is good anatomical evidence for adren ergic and cholinergic nerves (and therefore recep tors) in pial arteries, but evidence only for adren ergic nerves intraparenchymally.
Physiological data have demonstrated the pres ence of muscarine receptors and adrenoreceptors in cerebral arteries. In vitro application of catechol amines to pial vessels generally produces contrac tion (Kuschinsky and Wahl, 1975; Edvinsson et ai., 1976) . Some authors have found biphasic dose-re sponse curves (Duckles and Bevan, 1976) to adren ergic agonists, and the low potency of norepineph rine and phenylephrine has led some investigators to suggest that a-receptors are different from those found in peripheral arteries (Edvinsson and Owman, 1974) . Responses to intravascular cate cholamines have been less well studied in the brain, but studies with peripheral vessels have suggested the presence of endothelial a2-adrenoreceptors (Langer et ai., 1980; McGrath, 1982) and that these mediate relaxation (Cocks and Angus, 1983) . The prevailing opinion is that neural control in pial ar teries is exerted at times of considerable stress, and J Cereb Blood Flow Metahol. Vol. 5, No.3, 1985 that sympathetic action can limit cerebral pressure changes and flow in hypertension. For example, sympathetic denervation appears to attenuate the development of cerebral vascular hypertrophy in chronic hypertension (Hart et ai., 1980) . By com parison, studies of blood flow suggest that intra parenchymal vessels are generally quite responsive to catecholamines, and that adrenoreceptors in cap illaries may modify water permeability as well as blood flow (Raichle et ai., 1975) . What is difficult to assess by this approach is the contribution of metabolic changes to vascular changes. Additional problems include wide variability in the responsive ness of different vessels in one species (McCulloch and Edvinsson, 1984) and in vessels from different species (Duckles, 1979; Lee et ai., 1982) .
Responses in situ and in vitro to cholinergic ag onists and antagonists have shown that acetylcho line generally dilates pial vessels by acting on mus carine receptors (Kuschinsky et ai., 1974; Lee et ai., 1978; Duckles, 1979) ; the site of action, how ever, has not been clear. The best present guess is that acetylcholine from nerves modulates the re lease of norepinephrine from adrenergic nerves (Edvinsson et ai., 1977; Shepperd et ai., 1978) , but this does not readily explain dilation, which more likely involves noninnervated receptors in endothe lial layers (Vanhoutte, 1981) . Cholinergic mecha nisms in intraparenchymal vessels have been studied only through indirect measurements of ce rebral blood flow, where vasodilation could be as sociated with secondary effects of metabolites.
Radioligand binding techniques and enzyme as says offer a different approach to the understanding of cerebrovascular control mechanisms. Specific binding of [3H]dihydroergocryptine has been found in hog pial arteries, suggesting the presence of a adrenoreceptors (Friedman and Davis, 1980) . Sim ilarly, binding of [3H]yohimbine was found in bo vine pial arteries, indicating a2-adrenoreceptors, al though specific binding for [3H]prazosin was not found (Tsukuhara et ai., 1983) . Our results with azi doclonidine confirm the presence of az-receptors in pial arteries and show that they are present in human vessels. Our results with prazosin represent the first clear demonstration of aI-receptors in pial arteries. This is in agreement with studies in vitro with large human pial arteries (Toda, 1983) . Con centration-response curves produced by norepi nephrine were antagonized in a competitive manner by prazosin, whereas yohimbine produced only a slight antagonism at high concentrations. By auto radiography we have observed binding sites for [3H]prazosin in the tunica intima as well as the tunica adventitia of human pial arteries, whereas
[3H]azidoclonidine binding sites are restricted to the endothelium (G. Ferrari-DiLeo and L. T. Potter, unpublished observations) . U]-, U2-' and �-receptors have also been found in binding experiments with bovine (Peroutka et aI. , 1980) , pig (Harik et aI. , 1981) , and rat (Kobayashi et aI. , 1981) microvessels. The present results extend knowledge of these u receptors to human intraparenchymal vessels.
Low levels of [3H]QNB binding have been found in bovine pial arteries (Estrada and Krause, 1982) , and choline acetyitransferase activity has also been determined in bovine (Estrada et aI. , 1983) and cat (Bevan et aI. , 1982) pial vessels. The present results show even lower levels of muscarine receptors and choline acetyltransferase activity in human pial ar teries, within a factor of 2-3 of levels that may be considered artifactual. This difference appears to be due to species differences since we have determined higher levels of muscarine receptors and choline acetyltransferase activity in bovine and rat pial ves sels under the same conditions used in this study. Autoradiography of pial vessels shows a few eH]QNB sites in adventitial nerves, but most in the tunica intima, far from the nerves (G. Ferrari-DiLeo and L. T. Potter, unpublished observations).
The presence of muscarine receptors in micro vessels has been more controversial. Several groups have measured radioligand binding and fo und low levels in bovine (Peroutka et aI. , 1980; Estrada et aI. , 1983) , pig, and rat (Harik et aI. , 1981) microvessels. The present results show levels of choline acetyltransferase activity and QNB binding in human microvessels that may be due to contam ination by brain tissue. Thus, the available evidence is not sufficient to support the idea of cholinergic control of intracerebral arterioles and capillaries.
